Adicet Bio, Inc. — Director's Dealing 2022

Nov 15, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2022-11-10

Reporting Person: Schor Chen (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-10	Common Stock	S	9955	$21.0268	Disposed	91469	Direct
2022-11-10	Common Stock	S	30000	$20.064	Disposed	53424	Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $21.00 to $21.18, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission ("SEC") staff upon request.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $20.00 to $20.27, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee.